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Abstract: 
Background: To describe the implementation and initial results of an audit-
feedback quality improvement (QI) initiative in Belgian diabetic foot clinics 
(DFCs).  
Methods: Using self-developed software and questionnaires, DFCs collected 
data in 2005, 2008 and 2011, covering characteristics, history, and ulcer 
severity, management and outcome of the first 52 patients presenting with 
a Wagner grade ≥2 diabetic foot ulcer (DFU) or acute neuropathic 
osteoarthropathy that year. QI was encouraged by meetings and by 
anonymous benchmarking of DFCs.  
Results: The first audit-feedback cycle was a pilot study. Subsequent 
audits, with a modified methodology, had increasing rates of participation 
and data completeness.  
Over 85% of DFCs participated and 3,372 unique patients were sampled 
between 2005 and 2011 (3,312 with a DFU and 111 with acute neuropathic 
osteoarthropathy). Median age was 70 years, median diabetes duration 
was 14 years and 64% were male. Fifty-one percent of DFUs were plantar 
and 29% were both ischemic and deeply infected. Ulcer healing rate at 6 
months significantly increased from 49% to 54% between 2008 and 2011. 
Management of DFUs varied between DFCs: 88% of plantar mid-foot ulcers 
were off-loaded (P10-P90: 64-100%) and 42% of ischemic limbs were 
revascularized (P10-P90: 22-69%) in 2011.  
Conclusions: A unique, nationwide QI initiative was established among 
DFCs, covering ulcer healing, lower-limb amputation and many other 
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aspects of diabetic foot care. Data completeness increased, partly thanks 
to questionnaire revision. Benchmarking remains challenging, given the 
many possible indicators and limited sample size. The optimized 
questionnaire allows future quality of care monitoring in DFCs. 
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Abstract 
 
Background: To describe the implementation and initial results of an audit-feedback 
quality improvement (QI) initiative in Belgian diabetic foot clinics (DFCs). 
Methods: Using self-developed software and questionnaires, DFCs collected data 
in 2005, 2008 and 2011, covering characteristics, history, and ulcer severity, management 
and outcome of the first 52 patients presenting with a Wagner grade ≥2 diabetic foot 
ulcer (DFU) or acute neuropathic osteoarthropathy that year. QI was encouraged by 
meetings and by anonymous benchmarking of DFCs. 
Results: The first audit-feedback cycle was a pilot study. Subsequent audits, with 
a modified methodology, had increasing rates of participation and data completeness. 
Over 85% of DFCs participated and 3,372 unique patients were sampled between 
2005 and 2011 (3,312 with a DFU and 111 with acute neuropathic osteoarthropathy). 
Median age was 70 years, median diabetes duration was 14 years and 64% were male. 
Fifty-one percent of DFUs were plantar and 29% were both ischemic and deeply infected. 
Ulcer healing rate at 6 months significantly increased from 49% to 54% between 2008 
and 2011. Management of DFUs varied between DFCs: 88% of plantar mid-foot ulcers 
were off-loaded (P10-P90: 64-100%) and 42% of ischemic limbs were revascularized 
(P10-P90: 22-69%) in 2011. 
Conclusions: A unique, nationwide QI initiative was established among DFCs, 
covering ulcer healing, lower-limb amputation and many other aspects of diabetic foot 
care. Data completeness increased, partly thanks to questionnaire revision. Benchmarking 
remains challenging, given the many possible indicators and limited sample size. The 
optimized questionnaire allows future quality of care monitoring in DFCs. 
 
Keywords: diabetic foot, audit-feedback, quality improvement
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Introduction 
 
Diabetic foot ulceration (DFU) is a common late-stage complication of diabetes, with up 
to 25% of individuals with diabetes experiencing a DFU in their lifetime and with high 
recurrence rates (1,2). It has a large impact both on quality of life (3) and on resource 
utilization, the latter mainly driven by long hospital stays (4,5). 
 While performing a foot exam in diabetic patients is an accepted quality of care 
indicator assessing the efforts of health care practitioners (HCPs) in preventing new 
DFUs (6), there are few established indicators for monitoring quality of DFU care in 
specialized diabetic foot clinics (DFCs). The Eurodiale study reported that actual care of 
DFUs did not correspond well to the management recommendations set forth in 
international guidelines and that their application showed high variability between DFCs 
(7). The authors of the Eurodiale study suggested that the existing guidelines were too 
general, and that the HCP’s personal beliefs too often guided treatment, resulting in an 
underuse of recommended treatment strategies. 
 Monitoring of performance and providing feedback to HCPs (audit-feedback), 
including benchmarking of DFCs, is one strategy to improve quality of care (8). In 2001, 
a quality improvement (QI) initiative based on audit-feedback cycles, covering both 
processes and outcomes of care, was established in over 100 Belgian hospital-based 
diabetes centres. This initiative improved adherence to diabetes care guidelines, mostly 
with regard to processes of care (9).  In 2005, the existing audit-feedback initiative was 
extended to Belgian multidisciplinary DFCs that complied with a predefined structure of 
care. The aim was to evaluate the impact of multidisciplinary care in these DFCs, but also 
to identify challenges and shortcomings in the implementation of DFU management 
recommendations with the aim of improving quality of care. Here, we describe the 
implementation of this QI initiative, its optimization over the years and the initial results, 
in terms of patient and ulcer characteristics, management and outcomes. 
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Materials and methods 
 
Study population 
Since 2005, Belgian multidisciplinary DFCs, assembling expertise from diabetologists or 
internists with experience in the treatment of diabetes, vascular and orthopedic surgeons, 
podiatrists, and wound care specialists, can apply for recognition by the health 
authorities. Recognized DFCs agree to provide true multidisciplinary care during 
consultation hours to patients suffering from diabetic foot problems. Other disciplines 
(dermatologists, pharmacists etc.) are involved in some DFCs but this is not necessary for 
recognition. 
To qualify for continued recognition, DFCs need to treat at least 52 diabetic 
patients with a new index “foot problem” each year: either a diabetic foot ulcer (DFU) of 
grade 2 or more, according to the Wagner wound classification system (10), or an acute 
neuropathic osteoarthropathy (acute Charcot foot). The audit-feedback initiative is 
limited to these 52 patients. If a DFC treats more patients meeting the criteria above, only 
the first 52 patients are considered for audit-feedback, leading to a more limited 
representativeness for the larger DFCs. Some DFCs choose to register more patients 
satisfying the above criteria to improve the representativeness of the feedback reports 
sent to them (see below). 
In order to investigate the representativeness of the obtained sample, DFCs were 
invited during the most recent audit (2011) to provide ulcer grading data and the presence 
of an acute Charcot foot for all their patients. This group of patients will be referred to in 
the text as the “2011 clinic population” and will be compared to the sample of 52 
patients, referred to as the “2011 audit sample”. 
 
Audit 
There have been 3 audits (2005, 2008 and 2011), using different study designs: entirely 
retrospective in 2005 and 2008, and mixed retrospective/prospective in 2011 (audit 
started 6 months after start of patient eligibility). All audits used a standardized electronic 
questionnaire with separate sheets for entry of baseline and follow-up data.  This 
questionnaire was developed during meetings with an expert committee composed of 
diabetologists, orthopedic and vascular surgeons, podiatrists, epidemiologists and experts 
in quality audits and QI. After each cycle, the methodology was reviewed and altered if 
deemed necessary. At baseline, the DFCs abstracted the following data from the patients’ 
medical records: age, sex, postal code, diabetes type and duration, smoking status, 
relevant medical history, referral pattern, type of foot problem (DFU and/or Charcot 
foot), and ulcer location and severity, according to both the Wagner (10) and PEDIS (11) 
classification systems. 
During follow-up (1 year in 2005 and 6 months in 2008 and 2011), management 
of the foot problem (off-loading, vascular diagnostics, revascularization, orthopedic 
surgery and podiatric interventions) and ulcer and patient outcomes (ulcer healing, major 
amputation, or death; relapse or new ulcers) were recorded by the DFCs. Ulcer healing 
was defined as complete epithelialization with or without minor amputation (amputation 
below the ankle). 
After completion of follow-up, DFCs transferred the data to the Scientific 
Institute of Public Health (IPH), an independent semi-governmental organization, for data 
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quality checks, analysis and generation of feedback reports. Participation is mandatory, 
possibly resulting in doubtful quality and validity of the data. To alleviate these concerns, 
health authorities do not have access to the raw data and they only see pooled results. The 
DFCs have to keep a list of the sampled patients for a possible on-site audit. The expert 
committee adopts a bottom-up approach and does not include representatives of the 
authorities. 
 
Feedback of data to DFCs 
DFCs received individualized feedback reports, containing the following analyses: (a) 
indications of data completeness, (b) comparison of the DFC’s patient and ulcer 
characteristics with those of the median DFC to allow identification of possible case-mix 
differences, and (c) scores and caterpillar plots (figure 1A and C) on selected quality of 
care indicators to allow benchmarking. During each cycle, pooled results were also 
presented and discussed during meetings open to all recognized DFCs and their team 
members. At the end of each cycle, a global report based on the pooled results was 
published (see http://www.wiv-isp.be/epidemio/), containing recommendations for future 
audit-feedback cycles and for improving quality of diabetic foot care in Belgian DFCs. 
 
Funnel plot analysis 
Two process-of-care quality indicators were chosen for a funnel plot analysis (12): (a) the 
rate of off-loading of plantar mid-foot ulcers (off-loading of ulcer, foot and/or lower leg 
by any means except by crutches, a wheelchair or bed rest), and (b) the rate of 
revascularization (endovascular or surgical) of ischemic limbs (PEDIS perfusion grade of 
2 or more). Funnel plots show the individual rate per DFC as a function of the number of 
plantar mid-foot ulcers or ischemic limbs (figure 1B and D). The sample size, which is 
plotted on the x-axis, is an interpretable measure of the precision with which the rates 
were measured. Superimposed are “control limits” which typically mark the threshold of 
2 and 3 standard deviations (SD) around the overall rate, roughly coinciding with the 
95.0% and 99.9% prediction limits (figure 1B and D). DFCs lying beyond the 2 SD limit 
were considered “outliers”. 
 
Statistical analysis 
For the description of patients and foot problems, data from the three audits were pooled. 
Unique patients were identified and only the episode pertaining to the first foot problem 
was kept for analysis. Statistical testing for differences in medians and proportions was 
done using the Kruskal-Wallis and χ
2
 test respectively. All analyses were done in Stata 
(version 10.1, StataCorp, College Station, TX, USA). Statistical significance was defined 
as P<0.05. No adjustment was made for multiple testing.
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Results 
 
Implementation of audit-feedback and methodological changes 
The number of recognized DFCs increased from 22 in 2005-2008 to 36 in 2009-2011. 
They were located in all regions of Belgium, although almost exclusively in urban areas 
and more often in the densely populated northern region. Audit participation rates were 
high and over 1,000 patients were sampled each audit (table 1). Some DFCs failed to 
provide valid data for the required minimum of 52 patients (table 1), although, barring 
some exceptions, they usually missed the target by only 1 or 2 patients. Fewer than 50 
patients were sampled by no DFCs in 2005, 1 DFC in 2008 (5%) and 5 DFCs in 2011 
(14%). 
After each cycle, the audit methodology was reviewed by an expert committee. 
The first audit was conceived of as a pilot study. One major methodological change was 
the shortening of the follow-up period from 1 year to 6 months after the first cycle of 
audit-feedback, making process and outcome data from 2005 incomparable to those of 
later audits.  
The questionnaires have been relatively stable in terms of characteristics and 
outcomes of patients and ulcers. By contrast, in an effort to more accurately reflect the 
care delivered, parameters pertaining to patient referral and management of the foot 
problem have undergone significant changes after the 2005 audit, both in terms of 
preciseness (definitions) and exhaustiveness (e.g. addition of questions on vascular 
diagnostics and podiatric interventions in 2008). 
 
Data completeness 
Tables 1 and 2 show that data completeness with regard to patient and ulcer 
characteristics significantly increased across the audits, except for reporting of known 
diabetes duration, diabetes type and ulcer location. In 2011, 14 DFCs participated for the 
first time. Data completeness for these first-time participants was not significantly lower 
than for the previously participating DFCs, except for a small difference in the reporting 
of ulcer location (98.2% for first-time participating DFCs vs. 99.8% for previously 
participating DFCs, P<0.01).  
 
Description of sampled patients and foot problems 
Between 2005 and 2011, 3,372 unique patients were sampled; 250 patients (7.4%) were 
sampled in 2 out of 3 audits and 21 patients (0.6%) were sampled in all 3 audits. 
Table 3 shows the characteristics of the unique patients. Patient characteristics 
were comparable for the 3 audits, except for sex (68.0% males in 2011 vs. 61.7% and 
62.0% in 2005 and 2008 respectively, P<0.01) and history of DFUs (45.7% in 2005 vs. 
58.7% and 59.5% in 2008 and 2011 respectively, P<0.001). 
Table 4 shows the ulcer characteristics of 3,312 unique patients with a DFU, of 
whom 51 patients (1.5%) had a concomitant acute Charcot foot. Severity of DFUs was 
graded more favorably across the audits (2005, 2008 and 2011), with regard to surface 
area (≥3 cm
2
 in 89.7, 84.3 and 66.9% respectively, P<0.001), perfusion ([sub]critical 
ischemia in 63.8, 62.1 and 57.2% respectively, P<0.01), and infection (deep or systemic 
infection in 53.2, 41.7 and 41.0% respectively, P<0.001). This was paralleled by 
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evolutions in DFU location (plantar location in 48.0, 54.2 and 51.1% respectively, 
P<0.05) and treatment delay (≥3 months in 7.6, 10.4 and 13.7% respectively, P<0.001). 
 Of all unique patients, 111 presented with an acute Charcot foot the first time they 
were sampled. 
 
Representativeness of the “audit sample” 
The audit-feedback initiative was limited to the first 52 patients that presented that year to 
the DFC with a new DFU of Wagner grade 2 or more and/or an acute Charcot foot. In 
order to investigate the representativeness of the obtained “audit sample” with regard to 
the total clinic population, DFCs were invited during the 2011 audit to provide limited 
data on ulcer grading and/or the presence of an acute Charcot foot for all their patients. 
This data with regard to total clinic population was provided by 23 out of 32 participating 
DFCs in 2011 (72.1%). 
In total, 2,491 patients were recorded over a period of 12 months (range: 69 to 
239 per DFC). The proportion of patients in the audit sample of 52 patients ranged from 
21.3% (for the largest DFC) to 87.0% (for the smallest DFC).  
Based on the ulcer severity data (N=2461), 708 DFUs (28.8%) were of Wagner 
grade 1, meaning that >70% of DFUs seen in daily practice were deep. The remaining 
DFUs of Wagner grade 2 or higher in the clinic population were compared to the DFUs 
in the audit sample (always Wagner grade 2 or higher), with regard to ulcer severity. 
Table 5 shows that, with regard to ulcer depth and infection, the observed severity 
distribution in the 2011 audit sample significantly differed from the expected distribution 
based on the data of the 2011 clinic population. Superficial ulcers and non-infected ulcers 
were significantly underrepresented in the audit sample, while deeply infected ulcers 
were significantly overrepresented. 
Of all patient data sets, 2,461 (98.8%) pertained to a DFU with or without a 
concomitant acute Charcot foot, and 76 (3.1%) pertained to an acute Charcot foot, with or 
without a concomitant DFU. Thus, 46 foot problems (1.8%) pertained to an acute Charcot 
foot with concomitant DFU. The corresponding proportions in the audit sample were 
99.1%, 2.7% and 1.8%, revealing no significant differences with regard to the clinic 
population. 
 
Patient and ulcer outcomes 
Table 6 shows the outcomes of patients with DFUs at 6 months of follow-up. Due to the 
longer follow-up period in 2005, only the 2008 and 2011 data will be considered. Among 
the 17 DFCs that participated both in 2008 and 2011, ulcer healing rate significantly 
increased, as well as the rate of minor amputation before healing. In parallel, the 
proportion of patients with a persisting DFU at 6 months significantly decreased (table 6). 
In the 2011 audit, these rates did not significantly differ between previously participating 
DFCs and first-time participants (N=14), except for healing after minor amputation, the 
rate of which was significantly lower in first-time participants (table 6). 
  
Variability of DFU management 
We investigated the overall evolution and the variability of 2 quality indicators: off-
loading of plantar mid-foot ulcers and revascularization of lower limbs with (sub)critical 
ischemia. 
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 8
 Among the 17 DFCs participating in both the 2008 and 2011 audits, off-loading 
rate was 87.2% in 2008 (N=196) and 88.8% in 2011 (N=196, P>0.05 vs. 2008). In 2011, 
the rate among first-time participating DFCs was 86.8% (N=144, P>0.05 vs. previously 
participating DFCs). The rates of revascularization of ischemic lower limbs were 39.4% 
in 2008 (N=480) and 44.0% in 2011 (N=514, P>0.05 vs. 2008) and 38.2% among first-
time participating DFCs in 2011 (N=343, P>0.05 vs. previously participating DFCs). 
 Figure 1B and D show that, in 2011, 2 and 5 DFCs respectively were situated 
below the lower 2 SD control limit for the 2 selected quality indicators. At the median 
sample size of 11 plantar mid-foot ulcers, a theoretical DFC would have to score >33 
percentage points below the overall off-loading rate in order to lie beyond the lower 
control limit and be termed an “outlier” (figure 1B). Similarly, at the median of 27 
ischemic limbs, the score would have to be >19 percentage points below the overall 
revascularization rate (figure 1D).  
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Discussion 
 
We succeeded in setting up a nationwide QI initiative with high participation rates, based 
on the principle of audit and feedback. Processes and outcomes of care among a sample 
of patients were recorded and the results were discussed during information meetings and 
fed back to the DFCs as benchmarking graphs. The initiative has gone through three 
audit-feedback cycles between 2005 and 2013. 
The initiative was conceptualized at a time when the Eurodiale study had already 
finished, but before its results were published. Therefore, the lessons learned from the 14 
select DFCs participating in Eurodiale (13) did not explicitly inform the design of the 
first audit-feedback cycle of the present initiative. Nevertheless, the expert committee 
included the Belgian participant of the Eurodiale study, so practical issues experienced in 
Eurodiale were included at an early stage. The German system for accreditation of DFCs 
started in 2003 (14) and in recent years there have been frequent exchanges to learn from 
each other’s systems, e.g. with regard to benchmarking and the organization of mutual 
visits between DFCs. 
The audit methodology was gradually improved and this was paralleled by a 
significant increase of data completeness. Moreover, in 2011, data completeness among 
DFCs participating for the first time equaled that among previously participating DFCs, 
possibly as a result of a clearer questionnaire and/or increased motivation among the 
newly recognized DFCs. We show that while there is statistical evidence that the DFUs 
in the audit sample were more severe than those in the total clinic population, the 
differences were small and unlikely to lead to biased results. 
 The main goal of this on-going initiative is to stimulate QI by benchmarking of 
DFCs. We found a significant increase of ulcer healing rates between 2008 and 2011. 
Scores for 2 key process indicators (6), off-loading of plantar mid-foot ulcers and 
revascularization of ischemic limbs, did not significantly increase in the same period. 
This observation highlights that outcomes and processes of care are not necessarily 
associated (15-17). Indeed, while we have not described all the recorded processes in this 
paper, it might well be the case that it does not matter so much whether a certain care 
process was provided, rather than how it was provided (i.e. the expertise with which it 
was carried out). This latter aspect is obviously difficult to measure in a large-scale audit, 
but might explain the discrepancy between processes and outcomes. While process 
measures are more robust than outcome measures, because they rely less on patient 
characteristics (16), the use of outcome measures is preferred when quality of care 
depends highly on technical expertise and skills (15,18). This is often the case in diabetic 
foot care, where skilled operators and well-organized teams are essential for successful 
and timely orthopedic surgery, vascular interventions and casting. 
Further research is needed to establish the reasons for the increased ulcer healing 
rate. A detailed analysis of patient and ulcer outcomes and their predictors was, however, 
beyond the scope of this paper and will be published separately. For now we will focus 
on the possible role of increased awareness thanks to the recognition of the DFCs and the 
existence of the QI initiative. First, the observation that ulcer severity at presentation 
steadily decreased across audits may explain the increased healing rate. It also suggests 
that diabetic foot care in primary care has improved, resulting in fewer severe DFUs 
presenting in DFCs, although this hypothesis remains to be tested. It is, however, 
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plausible that recognition of the DFCs has brought increased attention to the issue of 
diabetic foot care and has resulted in QI beyond the DFCs themselves. A second possible 
explanation for the improved outcomes is increased awareness to specific issues and 
improved knowledge among DFC team members themselves. Indeed, in addition to the 
information meetings organized within this QI initiative, the recognized DFCs have 
organized, in collaboration with patient organizations, further symposia after each of the 
three cycles, focusing successively on off-loading, vascular interventions and infection. 
Although our results do not show that off-loading and revascularization were practiced 
more often between 2008 and 2011, the information meetings and symposia may have 
contributed to more appropriate and skilled interventions and may thus have led to 
improved outcomes. 
 To our knowledge, this is the first initiative to provide routine benchmarking of 
specialized diabetic foot care (processes and outcomes) to DFCs. Compared to certain 
other fields, benchmarking of DFCs is challenging. First, patient volume in DFCs is 
usually relatively low as compared to other areas of medicine where benchmarking is 
used. Moreover, given the exhaustiveness of the questionnaire in this initiative (see 
below), it was not feasible to collect the data of all patients and a trade-off had to be 
made. This made it hard to detect differences in care, because indicator scores could only 
be estimated with relatively low confidence, as exemplified by the funnel plot analysis in 
figure 1 (19-22). Clearly, providing benchmarking with regard to the care of acute 
Charcot foot is impossible given its low incidence. This does not, however, preclude the 
implementation of continuous and long-term quality monitoring systems within DFCs 
that would allow follow-up of foot care, e.g. by using control charts (23). Examples could 
be the use of a p-chart (23) to evaluate casting techniques by monitoring the frequency of 
de novo ulceration, or an xmr-chart (23) for monitoring the duration of immobilization 
until cooling down of an acute Charcot foot. Second, given the complex pathophysiology 
of DFUs and acute Charcot foot, many parameters need to be collected to understand the 
severity and treatment of the foot problem and to predict its outcomes. Thus, many 
aspects of care could potentially be benchmarked, but there is no consensus as to which 
aspects matter most. For instance, the use of major amputation rate as a quality indicator 
has been criticized (24), because it depends, among other things, on disease prevalence, 
referral time and availability of resources. However, this can be said of any outcome 
measure, e.g. also of ulcer healing rates. In time, our initiative will be able to provide 
guidance in this area as the association of processes to outcomes of care becomes clearer. 
Although we show that benchmarking is challenging, simply collecting data and 
discussing the results is a very meaningful endeavor from a QI perspective. We agree 
with the guidelines from the International Working Group on the Diabetic Foot when 
they recommend that auditing should be part of the organization of diabetic foot care in 
any region (6), taking into account that the efforts required for data collection and 
analysis should be balanced by the expected benefits. 
In our experience, the following lessons are useful for future QI initiatives. (a) We 
have evolved from retrospective to prospective data collections, not only to improve data 
quality, but also to highlight the importance of continuous record keeping and to further 
instill among data providers a sense of “quality-thinking”, something which is not 
necessarily the case with retrospective data collections, where data providers are 
gathering data for only a limited amount of time (e.g. several days a year). (b) A pilot 
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phase is essential to arrive at an optimal questionnaire. Capturing the day-to-day reality 
of multidisciplinary diabetic foot care in a questionnaire is indeed challenging. After the 
pilot phase, we dropped or rephrased irrelevant or hard to interpret questions, thus 
simplifying data gathering. 
While the demographics and medical history of the patients in the present study 
were comparable to those of the Eurodiale study, the ulcers were, due to different 
inclusion criteria, more severe (25). Compared to studies including less severe ulcers 
and/or with a longer follow-up duration (14,17,25,26), the achieved healing, amputation 
and mortality rates were favorable. 
  The rates of off-loading and revascularization in the current report were higher 
than among the 14 select Eurodiale DFCs (7), although there was still room for 
improvement and results with regard to off-loading might be difficult to compare given 
the different definitions. However, as stated above, it remains to be established whether 
higher rates for key processes in DFU management, mentioned in current guidelines (6), 
will lead to better outcomes. The cyclical nature of our quality initiative will reveal 
whether improved adherence to guidelines will lead to better outcomes, and, should this 
not be the case, whether more specific guidelines (7) or other interventions are needed. 
In conclusion, it is feasible to implement a nationwide QI initiative among DFCs. 
The current methodology yields real-life data, allowing quality monitoring on a national 
level as well as in individual DFCs, and it affords us a better understanding of barriers to 
high quality care as well as of areas where QI is possible. 
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Tables 
Table 1: Participation rates and data completeness of reported patient characteristics across the 3 audits. 
 2005 2008 2011 P
a
 
Participating DFCs, n/N (%) 19/22 
(86.4) 
19/21 
(90.5) 
32/36 
(88.9) 
- 
Sampled patients, N (range of sampled patients per DFC) 1,048 
(50-75) 
1,006 
(2-70) 
1,600 
(23-60) 
- 
Sex
b
 100.0 100.0 100.0 - 
Birth year
b
 100.0 100.0 100.0 - 
Diabetes duration 77.2 75.0 78.6 0.106 
Diabetes type 98.6 98.8 98.1 0.362 
Smoking status 71.1 89.9 94.4 <0.001 
Cardiovascular history
c
  95.9 96.0 99.6 <0.001 
History of renal insufficiency or ESRD
d
 96.3 96.3 98.6 <0.001 
History of lower limb revascularization or angioplasty 96.5 95.1 99.1 <0.001 
History of diabetic foot ulcer 93.7 96.2 99.1 <0.001 
History of minor amputation
e
 N.D. 95.7 99.3 <0.001 
History of major amputation
e
 N.D. 94.5 97.7 <0.001 
Table shows percentage of patients for whom each data element was reported. 
a
 P-value for χ
2
 test 
b
 These parameters were obligatory. 
c
 Defined as history of myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention, stroke, or transient 
ischemic attack. 
d
 Defined as either (1) serum creatinine > 1.5 mg/dL or MDRD eGFR < 50 mL/min/1.73 m
2
 (in 2005 and 2008 only the first criterion 
was used) or (2) end-stage renal disease (ESRD, defined as renal transplantation or peritoneal or hemodialysis). 
e
 Minor amputation was defined as amputation below the ankle. Any amputation above that level was a major amputation. Not 
determined (N.D.) for patients sampled in 2005. 
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Table 2: Data completeness of reported ulcer characteristics across the 3 audits. 
 2005 2008 2011 P
a
 
Sampled DFUs, N 1,010 992 1,584 - 
Ulcer location 98.8 98.5 99.1 0.340 
Wagner grade 99.5 99.4 100.0 0.012 
Lower-limb perfusion (PEDIS-Perfusion) 93.8 97.7 98.2 <0.001 
Ulcer surface area
b
 (PEDIS-Extent) 75.3 83.0 96.6 <0.001 
Ulcer depth (PEDIS-Depth) 93.8 98.9 98.9 <0.001 
Ulcer infection (PEDIS-Infection) 94.5 97.8 99.1 <0.001 
Foot sensation (PEDIS-Sensation) 89.9 95.4 98.2 <0.001 
Treatment delay
c
 60.8 80.7 90.1 <0.001 
Table shows percentage of ulcers for which each data element was reported. 
a
 P-value for χ
2
 test 
b
 Surface area was collected as a continuous variable in 2005 and 2008 and was categorized during data analysis. 
c
 Treatment delay was defined as time elapsed between onset of DFU and 1
st
 presentation in the DFC. Treatment delay was collected 
as a continuous variable in 2008 and 2011 and was categorized during data analysis. 
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Table 3: Characteristics of all unique sampled patients (2005-2011), at the time of their first sampling. 
Sampled patients, N 3,372 
Male:female ratio 1.815:1 
Age, years 70 (60-78) 
Diabetes duration, years (N=2,597) 14 (7-22) 
Diabetes type, % T1/T2/other (N=3,317) 9.6/89.1/1.3 
Smoking, % never/quit/current (N=2,891) 50.5/30.3/19.2 
Cardiovascular history
a
  (N=3,283) 37.8 
Renal insufficiency or ESRD
b
 (N=3,275) 31.7 
History of lower limb revascularization or angioplasty (N=3,273) 29.3 
History of diabetic foot ulcer (N=3,258) 55.2 
History of minor amputation
c
 (N=2,281) 22.5 
History of major amputation
c
 (N=2,246) 3.7 
Data are presented as median (interquartile range) or as percentage. 
a
 Defined as history of myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention, stroke, or transient 
ischemic attack. 
b
 Defined as either (1) serum creatinine > 1.5 mg/dL or MDRD eGFR < 50 mL/min/1.73 m
2
 (in 2005 and 2008 only the first criterion 
was used) or (2) end-stage renal disease (ESRD, defined as renal transplantation or peritoneal or hemodialysis). 
c
 Minor amputation was defined as amputation below the ankle. Any amputation above that level was a major amputation.
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Table 4: Location and severity of sampled DFUs of all unique patients (2005-2011). 
Sampled DFUs, N 3,312 
Location: plantar (N=3,272) 50.9 
Location: not limited to toes (N=3,272) 48.7 
Surface area
a
 ≥3 cm
2
 (N=2,870) 77.3 
Depth: probing to bone (N=3,223) 30.7 
Wagner grade ≥3 (N=3,302) 47.8 
Loss of protective sensation (N=3,141) 84.8 
(Sub)critical limb ischemia (N=3,205) 60.5 
Deep or systemic infection (N=3,225) 44.8 
Ischemic and deeply infected DFUs
b
 (N=3,219) 28.7 
Ischemic and deeply infected DFUs
b
, not limited to toes (N=3,249) 12.6 
Treatment delay
c
, % <1 / 1-2 /  ≥3 months (N=2,598) 62.0/26.6/11.4 
Data are presented as median (interquartile range) or as percentage. 
a
 Surface area was collected as a continuous variable in 2005 and 2008 and was categorized during data analysis. 
b
 Combination of (sub)critical ischemia with a deeply infected DFU or systemic infection. 
c
 Treatment delay was defined as time elapsed between onset of DFU and 1
st
 presentation in the DFC. Treatment delay was collected 
as a continuous variable in 2008 and 2011 and was categorized during data analysis.
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Table 5: Distribution of ulcer severity according to the PEDIS classification among all patients during the 2011 audit period and 
among sampled patients, limited to a subset of 23 DFCs. 
 2011 clinic population, n (%) 2011 audit sample, n (%) P
a
 
Perfusion, known 1,651 (100.0) 1,172 (100.0)  
   No PAD 666 (40.3) 499 (42.6) 0.129 
   Subcritical ischemia 723 (43.8) 518 (44.2)  
   Critical ischemia 262 (15.9) 155 (13.2)  
Extent, known 1,652 (100.0) 1,162 (100.0)  
   <1 cm
2
 548 (33.2) 399 (34.3) 0.102 
   1-2 cm
2
 693 (41.9) 514 (44.2)  
   ≥3 cm
2
 411 (24.9) 249 (21.4)  
Depth, known 1,651 (100.0) 1,183 (100.0)  
   Superficial 194 (11.8) 99 (8.4) 0.010 
   Deep 906 (54.9) 691 (58.4)  
   Probing to bone 551 (33.4) 393 (33.2)  
Infection, known 1,648 (100.0) 1,184 (100.0)  
   No infection 557 (33.8) 300 (25.3) <0.001 
   Superficial 502 (30.5) 373 (31.5)  
   Deep 497 (30.2) 438 (37.0)  
   Systemic 92 (5.6) 73 (6.2)  
Sensation, known 1,643 (100.0) 1,174 (100.0)  
   No LOPS 242 (14.7) 178 (15.2) 0.751 
   LOPS 1,401 (85.3) 996 (84.8)  
Abbreviations: LOPS, loss of protective sensation; PAD, peripheral artery disease. 
a
 P-value for χ
2
 test
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Table 6: Patient and ulcer outcomes at a maximum follow-up of 6 months. Patients were followed up until ulcer healing, major 
amputation or death, whichever occurred first. 
 Audit Period 
 2008 2011 
  Previously (2008) 
participating DFCs 
First-time 
participating DFCs 
Patients/ulcers, N 816 861 635 
Ulcer healing, % 48.7 53.7* 51.5 
   Healed after minor amputation, % 9.3 13.0* 8.7° 
Major amputation, % 3.8 3.7 4.6 
Died before healing, % 3.8 4.5 3.1 
   Died after major amputation, % 0.7 0.7 0.3 
Persisting DFU, % 44.5 38.8* 41.1 
* P < 0.05 vs. 2008 
° P < 0.05 vs. 2011 rate of previously participating DFCs
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Figure legends 
 
Figure 1: A and C. Caterpillar plots for the indicator “Percentage of plantar mid-foot 
ulcers off-loaded” (top) and “Percentage of ischemic limbs revascularized” (bottom), as 
provided in the 2011 feedback report to diabetic foot clinic (DFC) “X” (in red). B and D. 
Funnel plots based on the data from panels A and C, additionally showing whether the 
score applies to a previously participating DFC (circles) or a first-time participant 
(triangles). The horizontal dashed line shows the overall indicator score and the funnel 
shaped dotted lines show the 2 (in black) and 3 (in grey) SD control limits. In case of two 
overlapping data points a vertical marker is shown. 
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